title: Where are oncofertility and fertility preservation treatments heading in 2016?
abstract: An improvement in the survival rates of cancer patients and recent advancements in assisted reproductive technologies have led to remarkable progress in oncofertility and fertility preservation treatments. Although there are several available or emerging approaches for fertility preservation, the limited evidence for each strategy is the greatest concern. In this review, we discuss the concerns on currently available options, and propose new approaches for fertility preservation that may be available in the future.
authors.affiliation: Department of Obstetrics & Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo, Tokyo, 113-8655, Japan.
authors.forename: Miyuki
authors.initials: M
authors.lastname: Harada
authors.affiliation: Department of Obstetrics & Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo, Tokyo, 113-8655, Japan.
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Osuga
mesh_terms: D000465:Algorithms; D018929:Cell Culture Techniques; D000066491:Clinical Decision-Making; D015925:Cryopreservation; D019468:Disease Management; D005260:Female; D005298:Fertility; D059247:Fertility Preservation / Q000379:methods; D006801:Humans; D066298:In Vitro Techniques; D007246:Infertility / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D008297:Male; D009369:Neoplasms / Q000150:complications / Q000453:epidemiology
keywords: drug delivery systems; fertility preservation; in vitro follicle growth; in vitro sperm development; oncofertility; oocyte cryopreservation; ovarian protection; ovarian tissue cryopreservation; uterine transplantation